
    
      In this clinical trial, we evaluated the effect of two weeks of low (50 mg/day), medium (100
      mg/day) or high dose (300 mg/day) doxycycline versus no medication in patients undergoing
      elective AAA repair. The effect of doxycycline treatment on MMP and cysteine proteases, and
      their respective inhibitors was evaluated in an integrative approach.
    
  